Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels.
Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels.
复制标题
牡荆素化合物 1 是一种从中草药中提取的新型提取物,通过增加 ROS 水平来抑制 DNA 损伤,从而抑制黑色素瘤细胞的生长。
DOI:
10.1186/s13046-018-0897-x
复制
发表时间:
2018-11-06
期刊:
影响因子:
--
通讯作者:
Peng C
中科院分区:
文献类型:
--
作者:
Liu N;Wang KS;Qi M;Zhou YJ;Zeng GY;Tao J;Zhou JD;Zhang JL;Chen X;Peng C
BackgroundVitex negundoL (Verbenaceae) is an aromatic shrub that is abundant in Asian countries. A series of compounds fromVitex negundohave been used in traditional Chinese medicine for the treatment of various diseases. Cutaneous melanoma is one of the most aggressive malignancies. A significant feature of melanoma is its resistance to traditional chemotherapy and radiotherapy; therefore, there is an urgent need to develop novel treatments for melanoma.MethodsWe first examined the effects of VB1 (vitexin compound 1) on cell viability by CCK-8 (cell counting kit) and Colony Formation Assay; And then, we analyzed the apoptosis and cell cycle by flow cytometry, verified apoptosis by Immunoblotting. The in vivo effect of VB1 was evaluated in xenograft mouse model. Potential mechanisms of VB1’s antitumor effects were explored by RNA sequencing and the key differential expression genes were validated by real-time quantitative PCR. Finally, the intracellular reactive oxygen species (ROS) level was detected by flow cytometry, and the DNA damage was revealed by Immunofluorescence and Immunoblotting.ResultsIn this study, we show that VB1, which is a compound purified from the seed of the Chinese herbVitex negundo, blocks melanoma cells growth in vitro and in vivo, arrests the cell cycle in G2/M phase and induces apoptosis in melanoma cell lines, whereas the effects are not significantly observed in normal cells. To study the details of VB1, we analyzed the alteration of gene expression profiles after treatment with VB1 in melanoma cells. The findings showed that VB1 can affect various pathways, including p53, apoptosis and the cell cycle pathway, in a variety of melanoma cell lines. Furthermore, we confirmed that VB1 restored the P53 pathway protein level, and then we demonstrated that VB1 significantly induced the accumulation of ROS, which resulted in DNA damage in melanoma cell lines. Interestingly, our results showed that VB1 also increased the ROS levels in BRAFi (BRAF inhibitor)-resistant melanoma cells, leading to DNA cytotoxicity, which caused G2/M phase arrest and apoptosis.ConclusionsTaken together, our findings indicate that vitexin compound 1 might be a promising therapeutic Chinese medicine for melanoma treatment regardless of BRAFi resistance.
登录
查看更多内容
DOI:
10.1126/science.1253735
发表时间:
2014-11-21
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Lo JA;Fisher DE
通讯作者:
Fisher DE
影响因子:
8.8
作者:
Kemper K;Krijgsman O;Kong X;Cornelissen-Steijger P;Shahrabi A;Weeber F;van der Velden DL;Bleijerveld OB;Kuilman T;Kluin RJC;Sun C;Voest EE;Ju YS;Schumacher TNM;Altelaar AFM;McDermott U;Adams DJ;Blank CU;Haanen JB;Peeper DS
通讯作者:
Peeper DS
影响因子:
9
作者:
通讯作者:
--
影响因子:
8
作者:
通讯作者:
--
影响因子:
7.2
作者:
Mollereau, Bertrand;Ma, Dali
通讯作者:
Ma, Dali